FOXM1 and eosinophilic esophagitis: FOXM1 inhibition may restore epithelial homeostasis and barrier integrity to mitigate hyperproliferation and basal cell hyperplasia through regulation of cell cycle-related gene and inflammatory cytokine in response to allergic inflammation, leading to improved symptoms in patients with EoE.